Life sciences companies should pay attention to an ongoing action in Delaware that could have implications for whether they can obtain (or be subjected to) U.S. discovery in international arbitration under 28 U.S.C. § 1782. Section 1782 is a powerful tool that permits litigants to obtain broad discovery in the United States for use in … Continue Reading
Congratulations to Greenberg Traurig’s Lori Cohen, Marc Mukasey, and Todd Wozniak, who have been selected as 2018 MVPs. The MVP series showcases standout attorneys who have had significant client wins and contributions to their practice areas in the last year. Lori, Marc, and Todd have a strong commitment to an elite level of client service, providing counsel founded … Continue Reading
GT is pleased to have achieved a win on behalf of our client Teva Pharmaceuticals USA, Inc. In May 2018, a U.S. Federal District Court Judge from the Central District of California granted Teva’s motion to dismiss in its entirety without leave to amend. In April 2017, Plaintiffs commenced an action in California’s Riverside County … Continue Reading
According to a recent study conducted by Lex Machina, a leading US based legal analytics company, over the last eight and a half years Greenberg Traurig attorneys in the US have defended more commercial litigation cases than any other firm, and also filed more commercial disputes on behalf of plaintiffs. This achievement is enhanced by … Continue Reading
